Salt Lake City, Utah, United States, October 2025 – Biomerics, a leading vertically integrated contract manufacturer serving the global interventional medical device market, has announced the appointment of Arun Mohan as its new Chief Executive Officer. Founder and current CEO Travis Sessions will transition to the role of Chairman of the Board, ensuring leadership continuity and ongoing alignment with the company’s strategic vision.
“This is a defining moment in Biomerics’ 30-year journey,” said Travis Sessions, Founder and outgoing CEO. “Our success has always been rooted in innovation, manufacturing excellence, and a relentless focus on serving our customers. Arun has the leadership, vision, and proven track record to take Biomerics to the next level. With the full support of the board, I am confident that under his leadership, we will continue to deliver transformative solutions for patients while expanding our global footprint. I look forward to working alongside him as Chairman.”
Bringing over two decades of leadership experience in medical device manufacturing and operational strategy, Arun Mohan most recently served as President of Biomerics’ Micro Metals Division, where he led a high-performing team recognized for exceptional customer satisfaction, operational excellence, and scalable growth. His leadership philosophy emphasizes customer centricity, employee empowerment, and innovation-driven execution.
Reflecting on his new role, Mohan said, “I am humbled and honored to lead Biomerics into its next chapter. Our mission is clear: to improve and save lives. To achieve this, we will place our customers at the center, invest in our people, and advance manufacturing excellence as the foundation of everything we do. Together, we will innovate boldly, grow responsibly, and build a company that not only leads in medtech manufacturing but also inspires pride in every employee and confidence in every customer.”
As CEO, Mohan will serve on Biomerics’ Board of Directors and oversee global operations, financial performance, and strategic growth initiatives, including expansion in the interventional device market. Sessions, who founded Biomerics in 1994, will remain actively engaged as Chairman, advising on strategic initiatives and future mergers and acquisitions. Under his leadership, Biomerics has grown from a single-site startup into a global medical technology partner with over 3,000 employees across 12 locations in the United States, Dominican Republic, and Costa Rica, serving 20 of the top 30 medical device OEMs worldwide.
About Biomerics
Founded in 1994, Biomerics is a trusted medical device contract manufacturer providing comprehensive engineering design, development, and manufacturing services for the interventional medical device industry. With vertically integrated capabilities and specialized Centers of Excellence, Biomerics delivers advanced solutions in performance materials, micromachining, precision extrusion, balloons and catheters, laser processing, guidewires, and complex assemblies. Headquartered in Salt Lake City, Utah, Biomerics operates under a certified ISO 13485:2016 quality system, is FDA registered, and maintains full compliance with FDA 21 CFR Part 820.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
